VANI Stock Analysis: Buy, Sell, or Hold?
VANI - Vivani Medical, Inc. Common Stock (DE)
$1.06
0.06 (6.00%)
▲
5d:
-1.85%
30d:
-10.17%
90d:
-13.82%
BUY
MODERATE Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 12, 2026
Smart Money Accumulation
VANI is down 10.7% this week, but smart money is accumulating calls. Top strike: $1 2026-05-15 with 2,451 OI. Call ratio: 100% View Scanner →
Strength: 10.0/10
Get Alerted When VANI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: VANI shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: VANI shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: VANI is currently trading at $1.06, which is considered oversold relative to its 30-day fair value range of $1.07 to $1.23.
Technical Outlook: Technically, VANI is in a strong downtrend. Immediate support is located at $0.92, while resistance sits at $1.24. The stock is showing strong short-term momentum, up 6.0% recently.
Market Sentiment: VANI has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $5.00 (+400.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, VANI is in a strong downtrend. Immediate support is located at $0.92, while resistance sits at $1.24. The stock is showing strong short-term momentum, up 6.0% recently.
Market Sentiment: VANI has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $5.00 (+400.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$1.07 -
$1.23
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
70.8%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.0%)
- BULLISH: Trading 400.0% below Wall St target ($5.00)
Fair Price Analysis
30-Day Fair Range
$1.07 -
$1.23
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$0.18
(17.4%)
Support & Resistance Levels
Support Level
$0.92
Resistance Level
$1.24
Current Trend
Strong Downtrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.63
Wall Street Target
$5.00
(+400.0%)
Share & Embed Analysis
Last updated: April 02, 2026 2:24 PM ET
Data refreshes hourly during market hours. Next update: 3:24 PM
Data refreshes hourly during market hours. Next update: 3:24 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VANI showing a specific setup today?
Insider Activity (6 Months)
7
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Gregg Williams
BUY
1575231 shares
2026-03-15
Gregg Williams
BUY
1351351 shares
2026-01-27
Gregg Williams
BUY
1737765 shares
2026-01-15
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$213 | 67 BUY |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 53 HOLD |
|
RYTM
Rhythm Pharmaceuticals I… |
STRONG BUY
12 analysts |
$138 | 61 BUY |
|
IMVT
Immunovant Inc |
STRONG BUY
14 analysts |
$40 | 58 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$109 | 50 HOLD |
